- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.11. | Brain+ A/S: Brain+ A/S updates its financial guidance for 2025 | 83 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT No. 2025-19
Copenhagen, Denmark, 19 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") updates its financial guidance for 2025 to reflect... ► Artikel lesen | |
| 06.11. | Brain+ A/S: Brain+ investor update - October | 87 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 6 November 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S reports continued commercial traction and operational expansion in its October investor update,... ► Artikel lesen | |
| 06.10. | Brain+ A/S: Brain+ appoints new Chief Financial Officer | 89 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-18Copenhagen, Denmark, 6 October 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has appointed Otto Rasmussen, an experienced financial... ► Artikel lesen | |
| BRAIN+ A/S Aktie jetzt für 0€ handeln | |||||
| 24.09. | Brain+ A/S: Brain+ launches first Ayla NHS pilot with one of the UK's largest primary care practices | 100 | GlobeNewswire (Europe) | NEWS RELEASECopenhagen, Denmark, 24 September 2025, Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an agreement with a large primary care practice in the South... ► Artikel lesen | |
| 16.09. | Brain+ A/S: Brain+ signs agreement with Agincare Homes - the fourth UK care home group to deploy effective dementia therapy with Ayla | 187 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, September 16, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed an agreement with Agincare Homes Holdings Ltd, UK ("Agincare")... ► Artikel lesen | |
| 15.09. | Brain+ A/S: The Chief Financial Officer to transition, replacement search has been initiated | 128 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-17
Copenhagen, Denmark, September 15, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") announces that its Chief Financial Officer... ► Artikel lesen | |
| 02.09. | Brain+ A/S: Brain+ expands its agreement with Southcare Homes Group to deploy Ayla across the group | 257 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 2 September 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or the "Company") has signed an expanded contract with Southcare Homes Group ("Southcare")... ► Artikel lesen | |
| 28.08. | Brain+ A/S: Brain+ publishes Half Year Report for 2025 | 209 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT - No. 2025-16Copenhagen, Denmark, August 28, 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
In H1 2025, Brain+ A/S ("Brain+" or "the Company") realized a net result of DKK -8.0... ► Artikel lesen | |
| 05.06. | Brain+ A/S: Brain+ signs agreement with UK care home group Majesticare deploying Ayla for effective dementia care | 124 | GlobeNewswire (Europe) | NEWS RELEASE
Copenhagen, Denmark, 5 June 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has signed a partnership with Majesticare, a leading UK care home provider... ► Artikel lesen | |
| 30.05. | Brain+ A/S: Brain+ A/S - Minutes of Annual General Meeting | 129 | GlobeNewswire (Europe) | Copenhagen, Denmark, 30 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, the Annual General Meeting was held in Brain+ A/S, ("Brain+" or "the Company"). A total of 16.45 % of... ► Artikel lesen | |
| 05.05. | Brain+ A/S: Brain+ selected for the NHS Dementia Innovators Programme in the UK | 269 | GlobeNewswire (Europe) | Copenhagen, Denmark, 5 May 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") has been selected for the Dementia Innovators Programme in the United Kingdom (UK),... ► Artikel lesen | |
| 16.04. | Brain+ A/S: Brain+ appoints CCO Devika Wood as new CEO | 311 | GlobeNewswire (Europe) | Copenhagen, Denmark, 16 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that the Board has appointed the Company's Chief Commercial Officer (CCO)... ► Artikel lesen | |
| 02.04. | Brain+ A/S: Brain+ announces outcome of unit rights issue | 273 | GlobeNewswire (Europe) | Copenhagen, Denmark, 2 April 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 19.03. | Brain+ A/S: Brain+ expands its UK sales pipeline to €+500,000 in revenue and reveals Key Performance Indicators | 190 | GlobeNewswire (Europe) | Copenhagen, Denmark, 19 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Brain+ A/S ("Brain+" or "the Company") today reports continued strong momentum in its sales pipeline, now exceeding €500... ► Artikel lesen | |
| 06.03. | Brain+ A/S: Brain+ resolves to carry out its earlier announced unit rights issue of up to approximately DKK 16 million | 353 | GlobeNewswire (Europe) | Copenhagen, Denmark, 6 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA... ► Artikel lesen | |
| 24.02. | Brain+ A/S - reduction of share capital by reducing face value per share | 202 | GlobeNewswire | The nominal share capital of Brain+ A/S will be reduced as of 26 February 2025 by reducing the face value of the company's shares from DKK 0.08 to DKK 0.01.
Name:
Brain+
ISIN:
DK0061670205
Short... ► Artikel lesen | |
| 12.02. | Brain+ A/S: Brain+ A/S - Minutes of Extraordinary General Meeting | 192 | GlobeNewswire (Europe) | Copenhagen, Denmark, 12 February 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Today at 08:00 CEST, an Extraordinary General Meeting was held in Brain+ A/S ("Brain+" or "the Company"). A total of... ► Artikel lesen | |
| 22.01. | Brain+ A/S: Brain+ restructures to reduce OPEX by 35%, maintaining €1M ARR target for end 2025 and now expecting break-even by mid-2026, and announces 50% secured intended Rights Issue | 253 | GlobeNewswire (Europe) | Copenhagen, Denmark, 22 January 2025 - Brain+ A/S (Nasdaq First North: BRAINP)Brain+ A/S ("Brain+" or the "Company") announces that today, its Board of Directors has decided to carry out a rights issue... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,860 | +1,06 % | Fresenius Kabi Expands Simplist Portfolio of Prefilled Syringes | ||
| FRESENIUS MEDICAL CARE | 40,900 | +0,47 % | Neue 3,250%-Anleihe von Fresenius Medical Care | Stuttgart (www.anleihencheck.de) - Fresenius Medical Care (ISIN DE0005785802/ WKN 578580) hat eine Unternehmensanleihe (ISIN XS3233499089/ WKN A460DH) mit einem Volumen von bis zu 500 Millionen Euro... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,140 | 0,00 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| ALIGNMENT HEALTHCARE | 19,090 | +0,05 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,520 | -0,16 % | PRESSESPIEGEL/Unternehmen: SIEMENS HEALTHINEERS, INSTONE, BÖRSE STUTTGART, VOLKSWAGEN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
SIEMENS HEALTHINEERS - Das größte Potenzial sieht Siemens-Healthineers-CEO... ► Artikel lesen | |
| GENEDX | 160,60 | -1,84 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,530 | -2,86 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,000 | -0,25 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| PROGYNY | 24,950 | -1,27 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GERRESHEIMER | 25,620 | -4,12 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| BETA BIONICS | 28,440 | -3,50 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,940 | -0,88 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| ADAPTHEALTH | 9,430 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| PACS GROUP | 31,460 | 0,00 % | PACS Group, Inc. - 8-K, Current Report | ||
| NEUROPACE | 16,020 | +2,50 % | NeuroPace, Inc.: NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases | MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued... ► Artikel lesen |
Das Unternehmen BRAIN+ A/S kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAIN+ A/S finden Sie auf Wallstreet Online.